Streetbeat News

Stock Prices

GILD

Deep-pocketed investors show a divided sentiment on Gilead Sciences (NASDAQ:GILD), with options activity suggesting a bullish and bearish split. Significant options trades indicate a target price range of $65.0 to $75.0. Gilead's stock is currently down by -1.33%, with an RSI suggesting it may be oversold. An analyst from UBS maintains a Neutral rating with a target price of $75. The company's next earnings report is due in 7 days.

Portfolio Pulse from Benzinga Insights

April 18, 2024 | 5:16 pm

LGCOF

SSNLF

Samsung Group is implementing a six-day workweek for executives across all units to address business uncertainties, including currency depreciation, rising oil prices, and high borrowing costs, following disappointing results in 2023. This includes executives from Samsung Electronics Co. Ltd (OTC:SSNLF), which reported a significant operating loss in its semiconductor business. The move is part of a broader trend among South Korean conglomerates to navigate industry downturns and geopolitical risks.

Portfolio Pulse from Franca Quarneti

April 18, 2024 | 5:11 pm

DIA

IWM

JETS

QQQ

SPY

TSLA

Stocks rose on Thursday, with the S&P 500 aiming to end a losing streak, driven by corporate earnings. The iShares Russell 2000 ETF and U.S. Global Jets ETF saw gains, while Tesla dropped after a Deutsche Bank downgrade. The Philadelphia Fed Manufacturing Index beat expectations, but existing home sales fell. Commodities and Bitcoin rallied. Key ETFs like SPDR S&P 500, Dow Jones, and Invesco QQQ Trust posted gains, with notable stock movements in Discovery Financial Services, Capital One, and others ahead of earnings.

Portfolio Pulse from Piero Cingari

April 18, 2024 | 5:11 pm

SIX

B. Riley Securities analyst Eric Wold upgraded Six Flags Entertainment (NYSE:SIX) from Neutral to Buy and increased the price target from $30 to $31.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 5:10 pm

EXPE

Wedbush analyst Scott Devitt reiterates a Neutral rating on Expedia Group (EXPE) and maintains a $130 price target.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 5:08 pm

BNTC

Benitec Biopharma Inc (NASDAQ:BNTC) reported positive interim clinical data from its BB-301 Phase 1b/2a study in Oculopharyngeal Muscular Dystrophy (OPMD), showing improvements in swallowing functions without severe side effects. Additionally, the company announced a $40 million PIPE financing, leading to a 24% increase in its stock price.

Portfolio Pulse from Vandana Singh

April 18, 2024 | 5:04 pm

FVRR

Fiverr Intl (NYSE:FVRR) has been the subject of diverse analyst evaluations over the last three months, with ratings ranging from bullish to bearish. The average 12-month price target for FVRR is now $31.75, down from $33.67, reflecting a 5.7% decrease. Analysts from firms like BTIG, JP Morgan, and Citigroup have adjusted their price targets and ratings, indicating a cautious outlook on the company's performance. Despite this, Fiverr's financial performance shows strong revenue growth and net margin, but challenges in ROE, ROA, and a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

April 18, 2024 | 5:02 pm

BIO

CCL

CZR

SPY

WBD

XLE

XLRE

96% of S&P 500 companies are trading below Wall Street targets, indicating potential profits. SPDR S&P 500 ETF Trust (SPY) fell 3.7% in April, the worst month since September 2023. Only the Energy Select Sector SPDR Fund (XLE) avoided losses, while the Real Estate Select Sector SPDR Fund (XLRE) dropped 10%. High inflation and geopolitical risks have increased market volatility, presenting buying opportunities. Top contrarian stocks include Globe Life (GL), Caesars Entertainment (CZR), Warner Bros. Discovery (WBD), Bio-Rad Laboratories (BIO), and Carnival Corp (CCL), all showing significant gaps between current prices and analyst targets.

Portfolio Pulse from Piero Cingari

April 18, 2024 | 5:01 pm

REG

Four analysts have recently published ratings on Regency Centers (NASDAQ:REG), showing a mix of bullish to indifferent sentiments. The average 12-month price target is now $68.25, a decrease from the previous $72.00. Analyst actions include adjustments to ratings and price targets, reflecting changes in market conditions and company performance. Regency Centers, a leading retail REIT, reported a revenue growth of 14.34% and faces challenges in profitability and asset utilization, with a net margin of 24.02% and ROA of 0.7%.

Portfolio Pulse from Benzinga Insights

April 18, 2024 | 5:01 pm

HON

Over the past 20 years, Honeywell Intl (NASDAQ:HON) has produced an average annual return of 9.05%, outperforming the market. A $1000 investment in HON 20 years ago would now be worth $5,765.51. Honeywell currently has a market capitalization of $124.24 billion.

Portfolio Pulse from Benzinga Insights

April 18, 2024 | 5:00 pm